# Dual Treatment With Lithium and Valproate in ALS.

> **NCT03204500** · PHASE2 · COMPLETED · sponsor: **El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez** · enrollment: 43 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis
- Amyotrophic Lateral Sclerosis, Sporadic

## Interventions

- **COMBINATION_PRODUCT:** Active treatment with dual therapy
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03204500
- **Lead sponsor:** El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-04
- **Final completion:** 2019-08
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2020-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204500, "Dual Treatment With Lithium and Valproate in ALS.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03204500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*